99
Participants
Start Date
October 16, 2020
Primary Completion Date
April 13, 2022
Study Completion Date
April 13, 2022
WX-081
WX-081 is not licensed yet. WX-081 will be used in arms A, B, C, WX-081+MBT.
Bedaquiline
This licensed drug will be used in arm F as positive comparator.
Standard treatment
Standard treatment will be used in arm D as positive comparator, according to the recommendations of WHO guidelines for diagnosis and treatment of tuberculosis.
Multi-drug background treatment (MBT)
MBT will be used in arm E, F as background treatment. The drugs used in MBT are all licensed drugs, and the treatment complies with the recommendations of WHO guidelines for diagnosis and treatment of tuberculosis.
Beijing Chest Hospital affiliated to Capital Medical University, Beijing
Shanghai Jiatan Pharmatech Co., Ltd
INDUSTRY